Fitch Ratings with a little more of an upbeat assessment.
Headlines via Reuters, no further details at this stage.
Headlines via Reuters, no further details at this stage.
Most Popular
Sponsored
WVE's obesity drug shows promise with fat loss & muscle preservation; AATD drug nears regulatory feedback.
Walmart's ad biz offers better risk-reward than Costco's premium valuation. WMT's 37% ad growth beats COST's 53x P/E.
MercadoLibre eyes loan book sales for fintech growth; AI aids credit scoring. Stock targets 35% upside.
Bitcoin faces $82K sell wall amid oil surge & Fed fears. Returns hinge on inflation & easing.
VBR returned 31.9% vs IJJ's 26.5%, with VBR's lower fees boosting value.
RCL faces earnings with mixed signals: revenue up 13.3% last qtr, but peers like AAL surged 5.2% on results.
US gas glut looms as exports surge. Permian supply cuts 2027 prices despite LNG demand.
Sponsored
Must Read